- Home
- WAVE vs HOWL Comparison
WAVE vs HOWL Comparison
Compare WAVE & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- HOWL
- Stock Information
- Founded
- WAVE 2011
- HOWL 2017
- Country
- WAVE Israel
- HOWL United States
- Employees
- WAVE N/A
- HOWL N/A
- Industry
- WAVE Electric Utilities: Central
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- WAVE Utilities
- HOWL Health Care
- Exchange
- WAVE Nasdaq
- HOWL Nasdaq
- Market Cap
- WAVE 35.0M
- HOWL 37.9M
- IPO Year
- WAVE 2021
- HOWL 2021
- Fundamental
- Price
- WAVE $6.50
- HOWL $0.99
- Analyst Decision
- WAVE Strong Buy
- HOWL Strong Buy
- Analyst Count
- WAVE 1
- HOWL 3
- Target Price
- WAVE $15.00
- HOWL $8.33
- AVG Volume (30 Days)
- WAVE 27.7K
- HOWL 270.1K
- Earning Date
- WAVE 05-08-2025
- HOWL 05-08-2025
- Dividend Yield
- WAVE N/A
- HOWL N/A
- EPS Growth
- WAVE N/A
- HOWL N/A
- EPS
- WAVE N/A
- HOWL N/A
- Revenue
- WAVE $168,000.00
- HOWL $1,143,000.00
- Revenue This Year
- WAVE $325.00
- HOWL N/A
- Revenue Next Year
- WAVE $85.71
- HOWL $733.33
- P/E Ratio
- WAVE N/A
- HOWL N/A
- Revenue Growth
- WAVE N/A
- HOWL N/A
- 52 Week Low
- WAVE $2.20
- HOWL $0.60
- 52 Week High
- WAVE $17.63
- HOWL $5.73
- Technical
- Relative Strength Index (RSI)
- WAVE 51.16
- HOWL 55.55
- Support Level
- WAVE $6.45
- HOWL $0.80
- Resistance Level
- WAVE $7.13
- HOWL $1.07
- Average True Range (ATR)
- WAVE 0.54
- HOWL 0.09
- MACD
- WAVE 0.09
- HOWL 0.02
- Stochastic Oscillator
- WAVE 51.72
- HOWL 70.37
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.